Literature DB >> 31666189

Macrophage iron retention aggravates atherosclerosis: Evidence for the role of autocrine formation of hepcidin in plaque macrophages.

Lin Xiao1, Gang Luo1, Xiaoping Guo1, Chunjie Jiang1, Hongmei Zeng1, Feng Zhou1, Yanyan Li2, Jiasheng Yu3, Ping Yao4.   

Abstract

Iron accumulation has been frequently found in atherosclerotic lesions, especially in macrophages/foam cells, but the exact mechanisms by which hepcidin induces iron retention in plaque macrophages and its roles in atherogenesis remain unknown. Double immunofluorescence staining showed colocalization of hepcidin-positive macrophages with ox-LDL, TLR4, p-p65 and ferritin light chain (ferritin-L) both in human and murine atherosclerotic lesions. RAW264.7 macrophages incubated with ox-LDL showed elevated expression of TLR4, p-p65, hepcidin, ferritin-L/H, CYP27A1, CD36, PPARγ, liver X receptor α (LXRα), and ATP binding cassette transporter A1/G1 (ABCA1/G1), as well as increased intracellular labile iron pool level and lipid accumulation. Ox-LDL-induced iron retention and lipid accumulation were aggravated by lipopolysaccharide but blocked by TAK-242, an antagonist of TLR4. Moreover, macrophage TLR4/NF-κB pathway activation and foaming triggered by ox-LDL was enhanced by ferric ammonium citrate or exogenous hepcidin but attenuated by hepcidin silencing or the use of iron chelator. Meanwhile, the addition of hepcidin stimulated CD36-mediated Dil-labeled-ox-LDL uptake and inhibited the LXRα-ABCA1/G1 pathway-dependent cholesterol efflux in macrophages, which was significantly reversed by 27-hydroxycholesterol but further exacerbated by cyclosporin A, a selective inhibitor of CYP27A1. Our study provided the evidence that iron trapped in atherosclerosis plaque macrophages contributes to cholesterol disequilibrium-initiated foam cell formation, which is provoked by the unique but largely unknown autocrine formation of hepcidin in plaque macrophages via activating the TLR4/NF-κB pathway when exposed to ox-LDL. Such findings, considering the intricate vicious cycle between macrophage hepcidin autocrine-triggered iron retention and cholesterol disequilibrium, may shed new light on the "iron hypothesis" of atherosclerosis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Cholesterol; Hepcidin; Iron; Macrophages

Mesh:

Substances:

Year:  2019        PMID: 31666189     DOI: 10.1016/j.bbalip.2019.158531

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  9 in total

Review 1.  In-depth review: is hepcidin a marker for the heart and the kidney?

Authors:  Rengin Elsurer Afsar; Mehmet Kanbay; Avsin Ibis; Baris Afsar
Journal:  Mol Cell Biochem       Date:  2021-05-04       Impact factor: 3.396

2.  Protective roles of apremilast via Sirtuin 1 in atherosclerosis.

Authors:  Dongkui Sui; Hua Yu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 3.  Programmed cell death in atherosclerosis and vascular calcification.

Authors:  Min Li; Zhen-Wei Wang; Li-Juan Fang; Shou-Quan Cheng; Xin Wang; Nai-Feng Liu
Journal:  Cell Death Dis       Date:  2022-05-18       Impact factor: 9.685

Review 4.  Ferroptosis: the potential value target in atherosclerosis.

Authors:  Siyu Ouyang; Jia You; Chenxi Zhi; Pin Li; Xiaoyan Lin; Xiaoqian Tan; Wentao Ma; Liang Li; Wei Xie
Journal:  Cell Death Dis       Date:  2021-08-10       Impact factor: 8.469

5.  Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation.

Authors:  Hongxia Li; Zhiqiang Cao; Lili Wang; Chang Liu; Hongkun Lin; Yuhan Tang; Ping Yao
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

Review 6.  Potential intervention target of atherosclerosis: Ferroptosis (Review).

Authors:  Jia Li; Ling Xu; Yi Xuan Zuo; Xue Qin Chang; Hai Tao Chi
Journal:  Mol Med Rep       Date:  2022-09-23       Impact factor: 3.423

Review 7.  Intravenous iron therapy and the cardiovascular system: risks and benefits.

Authors:  Lucia Del Vecchio; Robert Ekart; Charles J Ferro; Jolanta Malyszko; Patrick B Mark; Alberto Ortiz; Pantelis Sarafidis; Jose M Valdivielso; Francesca Mallamaci
Journal:  Clin Kidney J       Date:  2020-11-26

Review 8.  Erythrocytes: Central Actors in Multiple Scenes of Atherosclerosis.

Authors:  Chloé Turpin; Aurélie Catan; Olivier Meilhac; Emmanuel Bourdon; François Canonne-Hergaux; Philippe Rondeau
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

Review 9.  Non-Transferrin-Bound Iron in the Spotlight: Novel Mechanistic Insights into the Vasculotoxic and Atherosclerotic Effect of Iron.

Authors:  Francesca Vinchi
Journal:  Antioxid Redox Signal       Date:  2021-03-22       Impact factor: 8.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.